Patent: 9,518,057
✉ Email this page to a colleague
Summary for Patent: 9,518,057
Title: | Derivatives and methods of treating hepatitis B infections |
Abstract: | Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject. |
Inventor(s): | Hartman; George D. (Lansdale, PA), Kuduk; Scott (Harleysville, PA) |
Assignee: | NOVIRA THERAPEUTICS, INC. (Doylestown, PA) |
Application Number: | 14/984,325 |
Patent Claims: | see list of patent claims |
Details for Patent 9,518,057
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | RECOMBIVAX, RECOMBIVAX HB | hepatitis b vaccine (recombinant) | Injection | 101066 | 07/23/1986 | ⤷ Try a Trial | 2034-12-30 |
Glaxosmithkline Biologicals | ENGERIX-B | hepatitis b vaccine (recombinant) | Injection | 103239 | 08/28/1989 | ⤷ Try a Trial | 2034-12-30 |
Hoffmann-la Roche Inc. | PEGASYS COPEGUS COMBINATION PACK | peginterferon alfa-2a and ribavirin | 125083 | 06/04/2004 | ⤷ Try a Trial | 2034-12-30 | |
Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | 06/13/2008 | ⤷ Try a Trial | 2034-12-30 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |